After 20 percent of the agency’s work force was cut, federal health officials have decided to bring back some experts and ...

As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...

HHS Robert F. Kennedy Jr. has railed against a “revolving door” between drug companies and the FDA. But HHS' actions now seem ...

The FDA is working with the food industry to eliminate petroleum-based artificial dyes from the U.S. food supply by late 2026 ...

Many conservatives want the FDA to impose tighter restrictions on mifepristone and misoprostol, which can be delivered by mail. The medication accounted for 63 percent of U.S. abortions in 2023. Amna ...

Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...

Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, ...

Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) announced that it had identified a suitor to take its subsidiary Pelthos Therapeutics public in an April 17th press ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union ...

HHS Secretary Robert F. Kennedy Jr.’s visit to the FDA Friday was supposed to introduce him as a trusted leader to agency employees. It did anything but. Over the course of 40 minutes ...